Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals

Molecular Endocrinology

Volumn 13, Issue 6, 1999, Pages 829-836

  Lange, Carol A ^a   Richer, Jennifer K ^a   Horwitz, Kathryn B ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN E; CYTOKINE; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE; PROTEIN P21; STAT PROTEIN; TRANSCRIPTION FACTOR;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER GROWTH; CELL GRANULE; CELL PROLIFERATION; GENE CONTROL; GROWTH INHIBITION; GROWTH STIMULATION; HORMONE ACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0033305372     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.6.0290     Document Type: Short Survey

References (39)

1. Progestin regulation of cellular proliferation
2. Physiological action of progesterone in target tissues
3. The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?
4. Estrogen and progestin regulation of cell cycle progression
5. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities
6. Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1)
7. Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21
8. Progestin effects on growth in the human breast cancer cell line T-47D-possible therapeutic implications
9. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor α, epidermal growth factor receptor, c-fos, and c-myc genes
10. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle
11. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development
12. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
13. Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line
14. Mechanisms of cyclin-dependent kinase inactivation by progestins
15. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways
16. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity
17. Cancer of the Breast
18. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47Dco human breast cancer cells by progestins: Implications for endocrine therapies
19. Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells
20. Estrogen and progesterone augment growth responsiveness of mammary tissue to cholera toxin
21. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition
22. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F
23. A sequence in the 5' flanking region confers progestin responsiveness on the human c-myc gene
24. STATs and gene regulation
25. Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation
26. Stat5a is mandatory for adult mammary gland development and lactogenesis
27. The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland
28. C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland
29. Functional interactions between Stat5 and the glucocorticoid receptor
30. Co-operation of progestational steroids with epidermal growth factor in activation of gene expression in mammary tumor cells
31. Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP/p300
32. Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21waf1/cip1 promoter in rat hepatoma cells
33. Role of the CCAAT/enhancer binding protein-α transcription factor in the glucocorticoid stimulation of p21waf1/cipl gene promoter activity in growth-arrested rat hepatoma cells
34. AF-2-dependent potentiation of CCAAT enhancer binding protein β-mediated transcriptional activation by glucocorticoid receptor
35. Transcriptional cross-talk, the second mode of steroid hormone receptor action
36. Inhibitory function of p21(Cip/WAF1) in differentiation of primary mouse keratinocytes independent of cell cycle control
37. A non-enzymatic p21 protein inhibitor of stress-activated protein kinase
38. New functional activities for the p21 family of CDK inhibitors